Identifying Opportunity, Placing Risk - Analyst Notes on CTI BioPharma, Vitae Pharmaceuticals, Giga-tronics and ChannelAdvisor

NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: CTI BioPharma Corp. (NASDAQ: CTIC), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE), Giga-tronics Inc. (NASDAQ: GIGA) and ChannelAdvisor Corp. (NYSE: ECOM). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

CTIC Research Package: http://www.traders-choice.com/pdf?s=CTIC

VTAE Research Package: http://www.traders-choice.com/pdf?s=VTAE

GIGA Research Package: http://www.traders-choice.com/pdf?s=GIGA

ECOM Research Package: http://www.traders-choice.com/pdf?s=ECOM

Highlights from today's reports include:

On Wednesday, December 23, 2015, NASDAQ Composite ended at 5,045.93, up 0.90%, Dow Jones Industrial Average advanced 1.06% to finish the day at 17,602.61 and the S&P 500 closed at 2,064.29, up 1.24%.

The stock of CTI BioPharma Corp. lost 1.59% to close Wednesday's session at USD 1.24, below its 50-day and 200-day moving averages of USD 1.29 and USD 1.68, respectively. The shares of the company moved in the range of USD 1.21 and USD 1.30. A trading volume of 1.18 million shares was recorded, which was lower than its 150-day daily average volume of 2.17 million shares and below its 52-week average volume of 2.40 million shares. Over the last five days CTI BioPharma Corp.'s shares have advanced 5.98% and in the past one month the stock has gained a momentum of 12.73%. Additionally, over the last three months the stock has declined 21.02% and in the past six months the shares have registered a loss of 43.38%. On a compounded total return basis, the company has returned 3.33% in the past one month. The stock is trading at a price to sales ratio of 12.93.

Vitae Pharmaceuticals Inc.'s stock advanced 5.65% to end Wednesday's session at USD 16.82. The share price oscillated between USD 15.81 and USD 17.95. The stock recorded a trading volume of 0.29 million shares, which was above its 50-day daily average volume of 0.22 million shares and its 52-week average volume of 0.24 million shares. The stock traded above its 50-day and 200-day moving averages of USD 13.67 and USD 12.46, respectively. Over the last three days Vitae Pharmaceuticals Inc.'s shares have advanced 3.83% and in the past one week the shares have moved up 13.27%. Moreover, in the last six months the stock has gained 3.57% and year to date the shares have picked up 1.08%. Further, the company is trading at a price to book ratio of 5.7. The price to sales ratio was recorded at 535.6.

The stock of Giga-tronics Inc. lost 3.90% to finish Wednesday's session at USD 1.48. The stock traded above its 50-day moving average of USD 1.38 while trading below the 200-day moving average of USD 1.53, respectively. The shares of the company moved in the range of USD 1.46 and USD 1.56. A trading volume of 0.19 million shares was recorded, which was lower than its 150-day daily average volume of 0.36 million shares. Over the last five days Giga-tronics Inc.'s shares have declined by 9.20% while in the past one month the stock has gained a momentum of 37.04%. Over the last three months the stock has advanced 32.95% while in the past six months the shares have registered a loss of 16.85%. On a compounded total return basis, the company has returned 32.14% in the past one month. Further, the stock is trading at a price to sales ratio of 0.64.

ChannelAdvisor Corp.'s stock increased by 1.67% to close Wednesday's session at USD 14.02, above its 50-day and 200-day moving averages of USD 12.10 and USD 11.29, respectively. The company’s shares fluctuated in the range of USD 13.78 and USD 14.25. A total of 0.13 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.26 million shares and its 52-week average volume of 0.32 million shares. Over the last three days ChannelAdvisor Corp.'s shares have advanced 2.11% while in the past one week the shares have moved down 3.38%. Over the last three months the stock has gained 31.77% and in the past six months the shares have picked up 11.36%. On a compounded total return basis, the company has returned 10.39% in the last half year. The stock is trading at a price to book ratio of 4.24, as against a historical PB ratio of 5.74. Additionally, the stock is trading at a price to sales ratio of 3.65.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.